What the COVID-19 pandemic has taught us about flu vaccines


Credit: CDC

A Recent reports According to a study by the National Academy of Science and Technology Medicine (NASEM), much must be done if you want to be prepared for a possible influenza pandemic, especially when it comes to the production and distribution of influenza vaccines.

At the beginning of 2021, NASEM convened an expert committee to investigate. supply chain Investigate distribution challenges associated with vaccines and vaccination during COVID-19 responses and their impact on pandemics and seasonal influenza.

In mid-November NASEM published a report on it. Expert panelClaims that a comprehensive and collaborative approach is needed to intensify global influenza vaccination Supply chain infrastructure, manufacturing, distribution, and management.

In other words, given the interrelated nature of the global vaccine supply chain, the COVID-19 pandemic has revealed that broken links represent a threat to health safety around the world. By accelerating the immunization of the particularly troublesome influenza virus around the world, the spread of the disease can be reduced. Therefore, as a national security issue, the United States needs to consider collaborative efforts to support / maintain the global vaccine supply chain.

The title of the NASEM report is “The Globally Resilience Supply Chain of Seasonal and Pandemic Influenza Vaccines.” For more information, we spoke with Jennifer Pancorvo, a vaccine manufacturing expert who serves as a panel and director of industry programs and research at the Center for Biomanufacturing Training and Education at North Carolina State University.

Summary: What are your areas of expertise related to the NASEM panel?

Jennifer Pancorbo: I’m a trained chemical engineer. I have been working in vaccine process development and manufacturing in general for about 15 years, especially for influenza vaccine process development and labor training for the past 11 years. My contribution to the panel was to take into account manufacturing and training perspectives.

TA: Why did NASEM decide to focus on the supply chain and influenza vaccines?

Pancorbo: It has been hypothesized for some time that the influenza virus is likely to cause a serious pandemic due to its ability to mutate and the pathway of respiratory infection. The global COVID-19 pandemic has exposed serious weaknesses in the vaccine and medical product supply chain, especially in the global coordination mechanism. The Commission was tasked with investigating distribution issues related to vaccination during the COVID-19 pandemic. Identify deficiencies in the global response to COVID pandemics and seasonal influenza. Make recommendations for action by US government agencies and stakeholders around the world.

TA: What are the important discoveries from your work?

Pancorvo: The Commission concluded that without a globally and locally distributed supply chain network, global supply and equitable access to pandemic influenza vaccines are uncertain and at high risk. Well-coordinated global organization ( Task forceA comprehensive governance structure allows us to coordinate our system approach to the production of influenza vaccines and our globally distributed supply chain. The G20 is an international organization with the appropriate scope to address these issues.

TA: You mentioned the “system approach” to the supply chain, what does that mean?

Pancorbo: The system approach provides end-to-end visualization of critical inputs. A comprehensive and well-coordinated organization defines, identifies and tracks the global real-time availability of critical inputs that constrain the potential supply required for vaccine production. Pandemic influenza.. Organizations then anticipate demand and ensure procurement, production, distribution, risk management, and coordination of these key components for different users. Importantly, these key components also include employee and training needs.

TA: Given that these supply chains are international and that public health itself is inherently international in the global economy, what can the United States do to implement these recommendations?

Pancorbo: The Department of Health and Human Services and its agencies, including various government agencies such as the Global Affairs Office, are working closely together. International organization Like the World Health Organization, it may provide technical and resource support to the proposed task force. It also draws attention to operational considerations when funding vaccine development programs, and is a new vaccine end-to-end technology that improves equitable access and indications for vaccines used at different temperature settings. We may also make global investments in.

Pandemic demand creates growth opportunities for domestic vaccine companies

Quote: COVID-19 Pandemic taught us about influenza vaccines (January 13, 2022) from https://medicalxpress.com/news/2022-01-covid-pandemic-taught-flu-vaccines.html Acquired on January 13, 2022.

This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. Content is provided for informational purposes only.

What the COVID-19 pandemic has taught us about flu vaccines Source link What the COVID-19 pandemic has taught us about flu vaccines

The post What the COVID-19 pandemic has taught us about flu vaccines appeared first on California News Times.


Please enter your comment!
Please enter your name here

Share post:


More like this

“They’re Panicked Because They Know the Current System is Doomed”

"They're Panicked Because They Know the Current System is...

BabyDoge Burns Diminish Those of SHIB by Record 46x as BabyDoge Sticks to Plan

Amount of BabyDoge burned in past 24 hours surpasses...

Exclusive Interview with Exeno CGO on World’s First Peer-to-peer Marketplace, Exeno Coin and Future Plans

Recently, I spoke with Gary Szlatiner, the chief growth...